M&R Capital Management Inc. Sells 460 Shares of iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

M&R Capital Management Inc. trimmed its holdings in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 1.6% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 27,713 shares of the financial services provider’s stock after selling 460 shares during the quarter. M&R Capital Management Inc.’s holdings in iShares Nasdaq Biotechnology ETF were worth $3,068,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also modified their holdings of the company. Stone House Investment Management LLC purchased a new stake in iShares Nasdaq Biotechnology ETF during the 1st quarter valued at about $27,000. Global Trust Asset Management LLC grew its position in iShares Nasdaq Biotechnology ETF by 89,733.3% during the 2nd quarter. Global Trust Asset Management LLC now owns 32,340 shares of the financial services provider’s stock valued at $32,000 after purchasing an additional 32,304 shares during the last quarter. Trustcore Financial Services LLC purchased a new stake in iShares Nasdaq Biotechnology ETF during the 1st quarter valued at about $34,000. Meridian Wealth Management LLC purchased a new stake in iShares Nasdaq Biotechnology ETF during the 1st quarter valued at about $36,000. Finally, Destination Wealth Management purchased a new stake in iShares Nasdaq Biotechnology ETF during the 1st quarter valued at about $42,000. Institutional investors own 72.66% of the company’s stock.

IBB stock traded down $1.31 during trading on Friday, hitting $105.07. 2,026,649 shares of the stock traded hands, compared to its average volume of 2,479,419. iShares Nasdaq Biotechnology ETF has a 1 year low of $89.01 and a 1 year high of $122.97. The stock has a 50 day simple moving average of $106.83.

iShares Nasdaq Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

See Also: Liquidity

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB).

Institutional Ownership by Quarter for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.